Two Sigma Investments
NVO

Two Sigma Investments’s Novo Nordisk NVO Stock Holding History

Two Sigma Investments’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$856K Sell
23,300
-108,700
-82% -$5.15M ﹤0.01% 3379
2025
Q4 		$6.72M Buy
+132,000
New +$6.75M 0.01% 1438

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Two Sigma Investments's NVO Position: Q1 2026 in Review

Two Sigma Investments increased its Novo Nordisk (NVO) stake by 1,732% in Q1 2026, buying an estimated $282M and bringing the position to 6,286,501 shares worth $231M. The position accounts for 0.19% of the portfolio, ranked #118.

Two Sigma Investments first reported a position in NVO in Q2 2013 and has held it in 38 quarters since. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Two Sigma Investments held 6,286,501 shares of Novo Nordisk worth $231M as of Q1 2026.
  • Two Sigma Investments bought 5,943,310 Novo Nordisk shares in Q1 2026, an estimated $282M.
  • Novo Nordisk made up 0.19% of Two Sigma Investments's portfolio in Q1 2026, its #118 holding.
  • Two Sigma Investments first reported a position in Novo Nordisk in Q2 2013 and has held it in 38 quarters since.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.